NEW STEP BY STEP MAP FOR HEMGENIX

Number of suitable sufferers: CDEC mentioned the uncertainty in the amount of people with reasonably significant to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific professionals consulted by CADTH indicated that some individuals who will be categorised as getting mild or average condition might have a serious